Tübinger Diabetes Mellitus Database (TUEDID)
ConditionDiabetes Mellitus
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorUniversity Hospital Tuebingen
About this trial
Diabetes mellitus is a widespread disease with increasing prevalence worldwide. Patients with diabetes can develop multiple late complications such as neuropathy, retinopathy, nephropathy and cardiovascular comorbidities. So far, there are no reliable predictive tools or markers to estimate if, when and to what extent a patient with diabetes develops late complications. For the patients quality of life and for health economic reasons an improved risk assessment would be desirable. The prospective TUEDID study will characterize diabetic patients to look out for parameters the predict progression of diabetes and its complications.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
>18 years
Disqualifiers
no written informed consent
Trial population
People with or without diabetes who are treated at the University Hospital Tübingen
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
1,000 Participants
are grouped into 1 trial groupGroup A: TUEDID cohort
Trial outcomes
Primary outcomes
1
Glycemic control (blood glucose)
Assessed as fasting blood glucose and HbA1C
Time frame
At enrolment2
Glycemic control (HbA1C)
Assessed as fasting HbA1C
Time frame
At enrolmentOther outcomes
1
Liver function
Parameters for liver function will be assessed (GOT, GPT, AP, Gamma-GT, Lipase, all \[U/l\])
Time frame
At enrolment2
Renal function
Parameters for renal function will be assessed (Creatinine, Urea, Cystatin C, all \[mg/dl\])
Time frame
At enrolment3
Glomerular filtration rate (GFR)
Glomerular filtration rate will be determined \[ml/min/1,73 m²\]
Time frame
At enrolment4
Lipid status
Parameters for evaluation of lipid status will be assessed (LDL, HDL, Cholesterol, triglycerides, all \[mg/dl\])
Time frame
At enrolmentSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov